Irfan Muhammad

Irfan Muhammad

Auto-generated profile, based on publicly available information

Irfan Muhammad

School of Resources and Environmental Engineering, Anhui University, Anhui Province Engineering Laboratory for Mine Ecological Remediation, Hefei 230601, Anhui, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2024 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
JHJie Hu
Jie Hu
Liqun ZhangLiqun Zhang
Liqun Zhang
WZWanyu Zhang
Wanyu Zhang
IMIrfan Muhammad
Irfan Muhammad
CYChuanyou Yin
Chuanyou Yin
Liugen ZhengLiugen Zheng
Liugen Zheng

21 February 2020 in Nanotechnology
Verified
Journal Article
Closed access
PDF file
RNRozita Nasiri
Rozita Nasiri
SDShadab Dabagh
Shadab Dabagh
RMRokhsareh Meamar
Rokhsareh Meamar
AIAni Idris
Ani Idris
IMIrfan Muhammad
Irfan Muhammad
HNHamid Rashidi Nodeh
Hamid Rashidi Nodeh
The present study aims at engineering, fabrication, characterization, and qualifications of papain (PPN) conjugated SiO 2 -coated iron oxide nanoparticles ‘IONPs@SiO 2 -PPN’. Initially fabricated iron oxide nanoparticles (IONPs) were coated with silica (SiO 2 ) using sol–gel method to hinder the aggregation and to enhance biocompatibility. Next, PPN was loaded as an anticancer agent into the silica coated IONPs (IONPs@SiO 2 ) for the delivery of papain to the HeLa cancer cells. This fabricated silica-coated based magnetic nanoparticle is introduced as a new physiologically-compatible and stable drug delivery vehicle for delivering of PPN to the HeLa cancer cell line. The IONPs@SiO 2 -PPN were characterized using FT-IR, AAS, FESEM, XRD, DLS, and VSM equipment. Silica was amended on the surface of iron oxide nanoparticles (IONPs, γ -Fe 2 O 3 ) to modify its biocompatibility and stability. The solvent evaporation method was used to activate PPN vectorization. The following tests were performed to highlight the compatibility of our proposed delivery vehicle: in vitro toxicity assay, in vivo acute systemic toxicity test, and the histology examination. The results demonstrated that IONPs@SiO 2 -PPN successfully reduced the IC 50 values compared with the native PPN. Also, the structural alternations of HeLa cells exposed to IONPs@SiO 2 -PPN exhibited higher typical hallmarks of apoptosis compared to the cells treated with the native PPN. The in vivo acute toxicity test indicated no clinical signs of distress/discomfort or weight loss in Balb/C mice a week after the intravenous injection of IONPs@SiO 2 (10 mg kg −1 ). Besides, the tissues architectures were not affected and the pathological inflammatory alternations detection failed. In conclusion, IONPs@SiO 2 -PPN can be chosen as a potent candidate for further medical applications in the future, for instance as a drug delivery vehicle or hyperthermia agent.